The estimated Net Worth of Martha Goldberg Aronson is at least $572 Тысяча dollars as of 31 May 2024. Ms. Aronson owns over 302 units of Cardiovascular Systems stock worth over $238,240 and over the last 14 years she sold CSII stock worth over $115,000. In addition, she makes $218,767 as Independent Director at Cardiovascular Systems.
Martha has made over 19 trades of the Cardiovascular Systems stock since 2010, according to the Form 4 filled with the SEC. Most recently she exercised 302 units of CSII stock worth $6,040 on 31 May 2024.
The largest trade she's ever made was buying 5,000 units of Cardiovascular Systems stock on 3 November 2010 worth over $195,000. On average, Martha trades about 956 units every 127 days since 2010. As of 31 May 2024 she still owns at least 11,912 units of Cardiovascular Systems stock.
You can see the complete history of Ms. Aronson stock trades at the bottom of the page.
Martha Goldberg Aronson Jr. serves as Independent Director of the Company. Ms. Goldberg Aronson has been a member of our Board since February 2017. Ms. Goldberg Aronson served as Executive Vice President of Strategic Planning at Ecolab, Inc., a specialty chemical company, from November 2015 to April 2016, and previously served as Ecolab’s Executive Vice President and President-Global Healthcare, from September 2012 to November 2015. Prior to Ecolab, Ms. Goldberg Aronson served as Senior Vice President and President, North America, of Hill-Rom Holdings, Inc., a leading worldwide manufacturer and provider of medical technologies and related services for the health-care industry, since August 2010. Before joining Hill-Rom, she served as Senior Vice President at Medtronic, Inc., from March 2008 to November 2009, and in various other domestic and international management positions with Medtronic, since 1991. She is also a director of Methode Electronics, Inc., CONMED Corporation and Clinical Innovations, LLC, and previously served as a director of Hutchinson Technology from 2010 to 2016, when it was acquired.
As the Independent Director of Cardiovascular Systems, the total compensation of Martha Aronson at Cardiovascular Systems is $218,767. There are 14 executives at Cardiovascular Systems getting paid more, with Scott Ward having the highest compensation of $4,718,960.
Martha Aronson is 53, she's been the Independent Director of Cardiovascular Systems since 2017. There are 13 older and 11 younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.
Martha's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor и Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
Cardiovascular Systems executives and other stock owners filed with the SEC include: